ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cognitive dysfunction"

  • Abstract Number: 1458 • ACR Convergence 2022

    Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment

    Delansie Lawrence1, Jiandong Su1, Andrea Knight2, Kathleen Bingham3, Mahta Kakvan1, Maria Carmela Tartaglia4, Leslet Ruttan5, Joan Wither6, May Choi7, Simone Appenzeller8, Nicole Anderson1, Dennisse Bonilla1, Patricia Katz9, Dorcas Beaton10, Robin Green5, Zahi Touma1 and Michelle Barraclough11, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Centre for Mental Health, University Health Network; Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4University of Toronto Krembil Neurosciences Centre, Toronto, ON, Canada, 5University Health Network-Toronto Rehabilitation Institute, Toronto, ON, Canada, 6Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8Unicamp, Campinas, São Paulo, Brazil, 9UCSF, San Rafael, CA, 10Institute for Work & Health, Toronto, ON, Canada, 11Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is highly prevalent in patients with systemic lupus erythematosus (SLE). Objective prevalence rates are reported as 38% [range: 20% to 80%]…
  • Abstract Number: 1459 • ACR Convergence 2022

    Evolution of Subjective Cognitive Impairment Overtime in SLE Patients: Bayesian Longitudinal Item Response Theory Modelling

    Michelle Barraclough1, Juan Pablo Diaz-Martinez2, Andrea Knight3, Kathleen Bingham4, Jiandong Su2, Mahta Kakvan5, Carolina Munoz2, Maria Carmela Tartaglia6, Leslet Ruttan7, Joan Wither5, May Choi8, Nicole Anderson9, Dennisse Bonilla2, Simone Appenzeller10, Ben Parker11, Patricia Katz12, Dorcas Beaton13, Robin Green7, Ian N. Bruce14 and Zahi Touma2, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Toronto, ON, Canada, 2Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 4Centre for Mental Health, University Health Network; Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 6University of Toronto Krembil Neurosciences Centre, Toronto, ON, Canada, 7University Health Network-Toronto Rehabilitation Institute, Toronto, ON, Canada, 8Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 9Schroeder Arthritis Institute, Krembil Research Institute and University Health Network, University of Toronto, Toronto, ON, Canada, 10Unicamp, Campinas, São Paulo, Brazil, 11Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 12UCSF, San Rafael, CA, 13Institute for Work & Health, Toronto, ON, Canada, 14Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Subjective cognitive impairment (SCI) is a significant problem in SLE and there are a lack of studies assessing change over time in SCI. The…
  • Abstract Number: 1468 • ACR Convergence 2022

    Apathy Measurement in a Cohort of Systemic Lupus Erythematosus

    Mike Putman1, David Gazeley2 and Ikechukwu Mbonu3, 1The Medical College of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, Wauwatosa, WI, 3Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Up to 40% of patients with systemic lupus erythematosus (SLE) have measurable cognitive dysfunction on neuropsychiatric testing. Around 83% of patients are nonadherent with…
  • Abstract Number: 1474 • ACR Convergence 2022

    Quinolinic Acid, a Kynurenine/Tryptophan Pathway Metabolite, Correlates with Abnormalities in Brain Structure and Function in SLE

    Erik Anderson, Chris Tang, An Vo, Cynthia Aranow, Bruce Volpe, Betty Diamond and Meggan Mackay, Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Stimulation of the kynurenine/tryptophan pathway by interferons alpha and gamma, both known contributors to SLE pathogenesis, leads to a potentially neurotoxic imbalance of pathway…
  • Abstract Number: 0164 • ACR Convergence 2021

    Disrupted Executive Control Network Structural-Functional Integration Is Associated with Inferior Performance of Cognitive Switching Tasks in Patients with Systemic Lupus Erythematosus (SLE)

    Xing Qian1, Danielle S Bassett2, Kwun Kei Ng1, Beatrice RY Loo1, Amelia J Koh1, Juan Helen Zhou1 and Anselm Mak3, 1Center for Sleep and Cognition, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 2Departments of Physics & Astronomy, Bioengineering, Electrical & Systems Engineering, Neurology, and Psychiatry, University of Pennsylvania, Philadelphia, PA, 3National University of Singapore, Singapore, Singapore

    Background/Purpose: Cognitive flexibility, a process that enables goal-oriented cognitive switching between mental function modes, is central to executive function which is impaired in SLE patients.…
  • Abstract Number: 0284 • ACR Convergence 2021

    Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study

    Elena Myasoedova1, Michelle Mielke1, Cassondra Hulshizer1, John Davis1, Vijay Ramanan1, Maria Vassilaki1 and Cynthia Crowson2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: Growing evidence from observational studies suggests that patients with rheumatoid arthritis (RA) are at increased risk for cognitive impairment and dementia. Longitudinal population-based studies…
  • Abstract Number: 0456 • ACR Convergence 2021

    Functional Connectivity, Enhanced Blood-Brain Barrier Leakage and Cognitive Impairment in Systemic Lupus Erythematosus

    John Hanly1, Jason Robertson1, Lyna Kamintsky1, Alon Friedman1, Steven Beyea1, John Fisk1, Antonina Omisade1, Cindy Calkin1, Tim Bardouille1, Chris Bowen1, Alexandra Legge1, Arnold Mitnitski2, Kara Matheson2 and Javeria Hashmi1, 1Dalhousie University, Halifax, NS, Canada, 2Nova Scotia Health Authority, Halifax, NS, Canada

    Background/Purpose: Cognitive impairment is the most frequent manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE), yet the mechanisms underlying it remain poorly understood. We have previously…
  • Abstract Number: 0777 • ACR Convergence 2021

    Potential Biomarkers of Cognitive Impairment in the Context of Childhood-Onset Systemic Lupus Erythematosus

    Santiago Arciniegas1, Sarah Mossad2, Tala El Tal3, Lawrence Ng4, Paris Moaf4, Helen Branson4, Adrienne Davis4, Linda Hiraki4, Deborah Levy4, Ashley Danguecan2 and Andrea Knight2, 1University of Toronto/The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Sick Children, Toronto, ON, Canada, 3University of Toronto/Hospital for Sick Children, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Cognitive complaints are common in children with childhood-onset systemic lupus erythematosus (cSLE), but neuropsychiatric lupus (NPSLE) remains challenging to diagnose and treat. To increase…
  • Abstract Number: 0859 • ACR Convergence 2021

    Evaluation of the Montreal Cognitive Assessment as a Screening Tool for Cognitive Dysfunction in Systemic Lupus Erythematosus

    Sudha Raghunath1, Yifat Glikmann-Johnston1, Eric Morand2, Julie Stout1 and Alberta Hoi3, 1Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 3Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia

    Background/Purpose: Cognitive dysfunction (CD) affects approximately 40% of SLE patients (1), impacting on employment, daily function, and quality of life (2)(3). Diagnostic neuropsychological testing is…
  • Abstract Number: 0872 • ACR Convergence 2021

    Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)

    Sudha Raghunath1, Yifat Glikmann-Johnston1, Emma Guymer1, Eric Morand2, Julie Stout1 and Alberta Hoi3, 1Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre Clayton, Melbourne, Australia, 3Department of Rheumatology, Monash Health & Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia

    Background/Purpose: Cognitive dysfunction (CD) is reported to affect approximately 40% of SLE patients (1). Mood disorders have been associated with both cognitive symptoms and cognitive…
  • Abstract Number: 0885 • ACR Convergence 2021

    SLE Phenotypes Formed from Machine Learning and Their Associations with Cognitive Impairment

    Michelle Barraclough1, Lauren Erdman2, Andrea Knight3, Juan Diaz-Martinez4, Kathleen Bingham5, Jiandong Su6, Mahta Kakvan6, Maria Tartaglia6, Lesley Ruttan5, Joan Wither6, May Choi7, Marvin Fritzler8, Dennisse Bonilla6, Dorcas Beaton9, Ben Parker10, Robin Green6, Patricia Katz11, Ian N. Bruce10 and Zahi Touma12, 1University of Manchester, University Health Network, Toronto, ON, Canada, 2The Hospital of Sick Children, Toronto, ON, Canada, 3Hospital for Sick Children, Toronto, ON, Canada, 4UHN, Toronto, ON, Canada, 5University of Toronto, University Health Network, Toronto, ON, Canada, 6University Health Network, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8University of Calgary, Calgary, AB, Canada, 9Institute for Work & Health, Toronto, ON, Canada, 10University of Manchester, Manchester, United Kingdom, 11University of California San Francisco, San Francisco, CA, 12University of Toronto, Mississauga, ON, Canada

    Background/Purpose: Cognitive impairment (CI) in SLE is a significant problem with limited treatment options. This is in part due to the uncertainty regarding the multifaceted…
  • Abstract Number: 0887 • ACR Convergence 2021

    Association of Mycophenolate and Azathioprine Use with Cognitive Function in SLE

    Chrisanna Dobrowolski1, Jiandong Su2, John McGinley1, Melissa Fazzari1, Kathleen Bingham3, Nicole Anderson2, Dorcas Beaton4, Lesley Ruttan3, Joan Wither2, Maria Tartaglia2, Mahta Kakvan2, Dennisse Bonilla2, May Choi5, Marvin Fritzler6, Patricia Katz7, Robin Green2, Chaim Putterman1 and Zahi Touma8, 1Albert Einstein College of Medicine, Bronx, NY, 2University Health Network, Toronto, ON, Canada, 3University of Toronto, University Health Network, Toronto, ON, Canada, 4Institute for Work & Health, Toronto, ON, Canada, 5Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 6University of Calgary, Calgary, AB, Canada, 7University of California San Francisco, San Francisco, CA, 8University of Toronto, Mississauga, ON, Canada

    Background/Purpose: Cognitive dysfunction (CD) is a common manifestation of systemic lupus erythematosus (SLE) which can have detrimental consequences for those affected. To date, no treatments…
  • Abstract Number: 0889 • ACR Convergence 2021

    Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients

    Ambika Gupta1, Sindhu Johnson2, Jiandong Su3, Andrea Knight4, Juan Diaz-Martinez5, Kathleen Bingham6, Mahta Kakvan3, Maria Tartaglia3, Lesley Ruttan6, Joan Wither3, May Choi7, Marvin Fritzler8, Dennisse Bonilla3, Dorcas Beaton9, Patricia Katz10, Robin Green3 and Zahi Touma1, 1University of Toronto, Mississauga, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University Health Network, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada, 5UHN, Toronto, ON, Canada, 6University of Toronto, University Health Network, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8University of Calgary, Calgary, AB, Canada, 9Institute for Work & Health, Toronto, ON, Canada, 10University of California San Francisco, San Francisco, CA

    Background/Purpose: Systemic Lupus Erythematosus (SLE) can lead to a number of neuropsychiatric manifestations including cognitive impairment (CI). Previous meta-analyses have reported the prevalence of CI…
  • Abstract Number: 0892 • ACR Convergence 2021

    Screening for Cognitive Impairment with the Automated Neuropsychological Assessment Metrics in Patients with Systemic Lupus Erythematosus

    Ruyi Pan1, Juan Diaz-Martinez2, Jessica Gronsbell1 and Zahi Touma3, 1University of Toronto, Toronto, ON, Canada, 2UHN, Toronto, ON, Canada, 3University of Toronto, Mississauga, ON, Canada

    Background/Purpose: The American College of Rheumatology Neuropsychological Battery (ACR-NB) is the standard screening test for cognitive impairment (CI) in systemic lupus erythematosus (SLE). While the…
  • Abstract Number: 0895 • ACR Convergence 2021

    Insight into Intraindividual Variability Across Neuropsychological Tests and Its Association with Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus

    Jennifer He1, Juan Diaz-Martinez2, Kathleen Bingham3, Jiandong Su4, Mahta Kakvan4, Maria Tartaglia4, Lesley Ruttan3, Dorcas Beaton5, Joan Wither4, May Choi6, Marvin Fritzler7, Nicole Anderson4, Dennisse Bonilla4, Robin Green4, Patricia Katz8 and Zahi Touma9, 1Western University, London, ON, Canada, 2UHN, Toronto, ON, Canada, 3University of Toronto, University Health Network, Toronto, ON, Canada, 4University Health Network, Toronto, ON, Canada, 5Institute for Work & Health, Toronto, ON, Canada, 6Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 7University of Calgary, Calgary, AB, Canada, 8University of California San Francisco, San Francisco, CA, 9University of Toronto, Mississauga, ON, Canada

    Background/Purpose: Dispersion is defined as the variability in an individual’s performance across multiple tasks at a single assessment visit. This measure has been studied in…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology